1 |
|
A missense mutation in the mitochondrial ND5 gene associated with a Leigh-MELAS overlap syndrome/
|
Crimi, M
|
Advanstar Communications [etc.]
|
2003
|
|
|
2 |
|
A model of atypical absence seizures: EEG, pharmacology, and developmental characterization/
|
Cortez, M A
|
Advanstar Communications [etc.]
|
2001
|
|
|
3 |
|
A mutated CCR5 gene may have favorable prognostic implications in MS/
|
Kantor, R
|
Advanstar Communications [etc.]
|
2003
|
|
|
4 |
|
Macrophage proteomic fingerprinting predicts HIV-1-associated cognitive impairment/
|
Luo, X
|
Advanstar Communications [etc.]
|
2003
|
|
|
5 |
|
Magnetization transfer imaging in focal epilepsy/
|
Rugg-Gunn, F. J
|
Advanstar Communications [etc.]
|
2003
|
|
|
6 |
|
Magnetization transfer imaging to monitor the evolution of MS: A 1-year follow-up study/
|
Filippi, M
|
Advanstar Communications [etc.]
|
2000
|
|
|
7 |
|
Malignant peripheral nerve sheath tumor: The clinical spectrum and outcome of treatment/
|
Baehring, J. M
|
Advanstar Communications [etc.]
|
2003
|
|
|
8 |
|
Malignant rolandic-sylvian epilepsy in children: Diagnosis, treatment, and outcomes/
|
Otsubo, H
|
Advanstar Communications [etc.]
|
2001
|
|
|
9 |
|
Management issues for women with epilepsy: Neural tube defects and folic acid supplementation/
|
Yerby, M. S
|
Advanstar Communications [etc.]
|
2003
|
|
|
10 |
|
Management of migraine: An algorithmic approach/
|
Silberstein, Stephen D
|
Advanstar Communications [etc.]
|
2001
|
|
|
11 |
|
Management of multiple sclerosis across managed care and fee-for-service systems
|
Vickrey, B G
|
Advanstar Communications [etc.]
|
2000
|
|
|
12 |
|
Managing epilepsy in a managed care organization/
|
Trost, Louis R
|
Advanstar Communications [etc.]
|
2001
|
|
|
13 |
|
Mania following temporal lobectomy/
|
Carran, M. A
|
Advanstar Communications [etc.]
|
2003
|
|
|
14 |
|
March 13 Highlights ///
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
15 |
|
March 27 Highlights/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
16 |
|
May 8 Highlights/
|
|
Advanstar Communications [etc.]
|
2001
|
|
|
17 |
|
Measurement of MxA mRNA or protein as a biomarker of IFNbeta bioactivity: Detection of antibody-mediated decreased bioactivity (ADB)/
|
Pachner, A. R
|
Advanstar Communications [etc.]
|
2003
|
|
|
18 |
|
Measuring Alzheimer's disease progression with transition probabilities: Estimates from CERAD/
|
Neumann, P J
|
Advanstar Communications [etc.]
|
2001
|
|
|
19 |
|
Mechanical compression of the extracranial vertebral artery during neck rotation
|
Sakaguchi, M
|
Advanstar Communications [etc.]
|
2003
|
|
|
20 |
|
Mechanism of action of deep brain stimulation/
|
Benazzouz, A
|
Advanstar Communications [etc.]
|
2000
|
|
|